Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc., as indicated in the metadata) on May 30, 2017. The registrant is a Delaware corporation with principal executive offices in San Diego, CA. The report addresses a specific regulatory event regarding the company's stock listing status on the NASDAQ Capital Market under the symbol "TROV".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the market price of the common stock, which has traded below $1.00 per share for 30 consecutive business days, triggering a non-compliance notice.
Material Changes
The material change reported is the receipt of a written notice from NASDAQ on May 30, 2017, stating that the Company is not in compliance with Listing Rule 5550(a)(2) due to the minimum bid price deficiency. This notice has no immediate effect on the listing, and the stock continues to trade.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until November 27, 2017, to regain compliance.
- Remediation Requirement: To regain compliance, the closing bid price must meet or exceed $1.00 per share for at least ten consecutive business days within the 180-day period.
- Contingencies: If compliance is not met by the deadline, the Company may be eligible for an additional 180-day grace period if it meets other initial listing standards and notifies NASDAQ of its intention to cure the deficiency, potentially via a reverse stock split.
- Risks: Failure to regain compliance within the allotted periods could result in delisting. The Company states there can be no assurance it will be able to regain compliance.
- Management Action: The Company intends to monitor the stock price and consider available options but has made no determination regarding its specific response at this time.
Investor Verification Checklist
- Verify the current trading price of TROV to assess the likelihood of meeting the $1.00 threshold within the 180-day window.
- Monitor future filings for announcements regarding a potential reverse stock split.
- Review the company's cash position in other filings (e.g., 10-Q or 10-K) to determine if it has sufficient liquidity to sustain operations if delisting occurs.
- Confirm the exact date the 180-day compliance period expires (November 27, 2017).